Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2-/- C57BL6 X Sv129 Helicobacter pylori-infected mice

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1520-1528

  Fox, James G ^a   Rogers, Arlin B ^a   Whary, Mark T ^a   Ge, Zhongming ^a   Ohtani, Masa ^a   Jones, Evelyn Kurt ^b   Wang, Timothy C ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROTEIN TREFOIL FACTOR FAMILY 2; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH ANTRUM DYSPLASIA; STOMACH EPITHELIUM; STOMACH TUMOR;

EID: 36348969455     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070249     Document Type: Article

References (49)

1. Taupin D, Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003, 4:721-732
2. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996, 274:259-262
3. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, Lee JY: Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000, 119:691-698
4. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC: Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996, 110:155-166
5. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, Jeon WK, Koh TJ, Fox JG: Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 1998, 114:675-689
6. Kang W, Rathinavelu S, Samuelson LC, Merchant JL: Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest 2005, 85:702-715
7. Obonyo M, Guiney DG, Harwood J, Fierer J, Cole SP: Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection. Infect Immun 2002, 70:3295-3299
8. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J: Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999, 67:279-285
9. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD: Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000, 165:1022-1029
10. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG: Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000, 118:36-47
11. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K, Peek RM Jr: Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003, 124:1879-1890
12. Dhar DK, Wang TC, Maruyama R, Udagawa J, Kubota H, Fuji T, Tachibana M, Ono T, Otani H, Nagasue N: Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 2003, 83:1343-1352
13. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, Goldenring JR: Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999, 79:639-646
14. Halldórsdóttir AM, Sigurdardottrir M, Jonasson JG, Oddsdottir M, Magnusson J, Lee JR, Goldenring JR: Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci 2003, 48:431-441
15. Yamaguchi H, Goldenring JR, Kaminishi M, Lee JR: Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 2002, 47:573-578
16. Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao CM, Podolsky DK, Wang TC: TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002, 109:193-204
17. Kurt-Jones EA, Cao L, Sandor F, Rogers AB, Whary MT, Nambiar PR, Cerny A, Bowen G, Yan J, Takaishi S, Chi AL, Reed G, Houghton J, Fox JG, Wang TC: Trefoil family factor 2 (TFF2) is expressed in murine gastric and immune cells and controls both gastrointestinal inflammation and systemic immune responses. Infect Immun 2007, 75:471-480
18. Cook GA, Familari M, Thim L, Giraud AS: The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Lett 1999, 456:155-159
19. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC: Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003, 63:942-950
20. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997, 112:1386-1397
21. Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG: Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res 2005, 65:10709-10715
22. Ward JM, Yoon M, Anver MR, Haines DC, Kudo G, Gonzalez FJ, Kimura S: Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am J Pathol 2001, 158:323-332
23. HogenEsch H, Dunham A, Seymour R, Renninger M, Sundberg JP: Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice. Exp Dermatol 2006, 15:808-814
24. Goldenring JR, Nomura S: Differentiation of the gastric mucosa: III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol 2006, 291:G999-G1004
25. Giraud AS: Metaplasia as a premalignant pathology in the stomach. Gastroenterology 2007, 132:2053-2056
26. Rogers AB, Cormier KS, Fox JG: Thiol-reactive compounds prevent nonspecific antibody binding in immunohistochemistry. Lab Invest 2006, 86:526-533
27. O'Rourke JL, Solnick JV, Neilan BA, Seidel K, Hayter R, Hansen LM, Lee A: Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 2004, 54:2203-2211
28. Ge Z, White DA, Whary MT, Fox JG: Fluorogenic PCR-based quantitative detection of a murine pathogen Helicobacter hepaticus. J Clin Microbiol 2001, 39:2598-2602
29. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999, 397:176-180
30. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539-547
31. Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, Fox JG: Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp Med 2001, 51:413-417
32. Rogers AB, Fox JG: Inflammation and cancer: I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol 2004, 286:G361-G366
33. Thompson LJ, Danon SJ, Wilson JE, O'Rourke JL, Salama NR, Falkow S, Mitchell H, Lee A: Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun 2004, 72:4668-4679
34. Fox JG, Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest 2007, 117:60-69
35. Ihrig M, Whary MT, Dangler CA, Fox JG: Gastric helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase. Infect Immun 2005, 73:1664-1670
36. Martin RM, Brady JL, Lew AM: The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 1998, 212:187-192
37. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J: Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005, 128:1937-1952
38. Zavros Y, Eaton KA, Kang W, Rathinavelu S, Katukuri V, Kao JY, Samuelson LC, Merchant JL: Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 2005, 24:2354-2366
39. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT: Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001, 98:13844-13849
40. Giraud AS, Pereira PM, Thim L, Parker LM, Judd LM: TFF-2 inhibits iNOS/NO in monocytes, and nitrated protein in healing colon after colitis. Peptides 2004, 25:803-809
41. Berg DJ, Lynch NA, Lynch RG, Lauricella DM: Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice. Am J Pathol 1998, 152:1377-1386
42. Yamamoto T, Kita M, Ohno T, Iwakura Y, Sekikawa K, Imanishi J: Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol Immunol 2004, 48:647-654
43. Karttunen R, Karttunen T, Ekre HP, MacDonald TT: Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995, 36:341-345
44. Eaton KA, Logan SM, Baker PE, Peterson RA, Monteiro MA, Altman E: Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wildtype C57BL/6J mice. Infect Immun 2004, 72:3925-3931
45. Cui G, Houghton JM, Finkel N, Carlson J, Wang TC: IFN-gamma infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter infection: a role for immune response in Helicobacter disease. Gastroenterology 2003, 124:A19
46. Padol IT, Hunt RH: Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut 2004, 53:1075-1081
47. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, Nagler-Anderson C: Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 2000, 6:536-542
48. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402
49. Thye T, Burchard GD, Nilius M, Muller-Myhsok B, Horstmann RD: Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet 2003, 72:448-453